Atlas FDA

TRUFILL n-BCA Liquid Embolic System

FDA premarket approval P990040/S038 · decided 2026-05-26

Approval details

PMA number
P990040
Supplement
S038
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TRUFILL n-BCA Liquid Embolic System
Generic name
tissue adhesive for use in embolization of brain arteriovenous malformations
Applicant
Cerenovus, Inc.
Date received
2026-04-21
Decision date
2026-05-26
Days to decision
35 days
Decision code
OK30
Product code
KGG
Advisory committee
Neurology
Expedited review
No
Location
Miami, FL
Statement
approval for implementation of alternate dry heat sterilization cycle parameters in a dedicated batch oven for TRUFILL n-BCA Liquid Embolization component manufactured and sterilized at Chemence Medical, Inc

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CEREGLIDE 71 Catheter System; Cerenovus Aspiration Tubing Set (K251828)Cerenovus, Inc.2025-08-22
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K241221)Cerenovus, Inc.2024-10-16
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (K241244)Cerenovus, Inc.2024-10-16
CEREGLIDE 92 Catheter System (K233982)Cerenovus, Inc.2024-05-09
Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing Set (K233988)Cerenovus, Inc.2024-01-17
CEREGLIDE 92 Intermediate Catheter (K230726)Cerenovus, Inc.2023-11-29
CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K221934)Cerenovus, Inc.2023-03-09
CEREGLIDE 71 Intermediate Catheter (K221930)Cerenovus, Inc.2023-03-09